Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Pyridine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL28416794 | 1.00 | TSHR (0.90) | — | |
| Pyridine SCHEMBL8733404 | 1.00 | TSHR (0.90) | — | |
| Pyridine SCHEMBL3801086 | 1.00 | TSHR (0.90) | — | |
| Pyridine SCHEMBL23609 | 1.00 | — | — | |
| Pyridine SCHEMBL11673636 | 1.00 | TSHR (0.90) | — | |
| Pyridine SCHEMBL2810359 | 1.00 | — | — | |
| Pyridine SCHEMBL8398481 | 1.00 | TSHR (0.90) | — | |
| Pyridine SCHEMBL3706898 | 1.00 | TSHR (0.90) | — | |
| Pyridine SCHEMBL8398488 | 1.00 | TSHR (0.90) | — | |
| Pyridine SCHEMBL28848391 | 1.00 | TSHR (0.90) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118204074-A | Cyclic ether MOF stabilized solitary atom catalyst and preparation and application thereof | 中国科学院大连化学物理研究所 | 2024-06-18 | — | — | CN | claimed |
| CN-104876856-B | A kind of method that Split Method prepares (R) (+) 3 amino piperidine dihydrochloride | 河北凯力昂生物科技有限公司 | 2017-11-21 | — | — | CN | claimed |
| US-20250110071-A1 | USING HYPERPOLARISED 15N DERIVED SYNTHONS TO CREATE HYPERPHARMACEUTICALS THROUGH SABRE | UNIVERSITY OF YORK (GB) | 2025-04-03 | — | — | US | disclosed |
| CN-111187202-B | NMDA antagonist prodrugs | 阿斯利康(瑞典)有限公司 | 2025-01-21 | — | — | CN | disclosed |
| WO-2023144521-A1 | USING HYPERPOLARISED 15N DERIVED SYNTHONS TO CREATE HYPERPHARMACEUTICALS THROUGH SABRE | UNIVERSITY OF YORK (GB) | 2023-08-03 | — | — | WO | disclosed |
| CN-116323707-A | Supported catalyst systems and methods of use thereof | 埃克森美孚化学专利公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-107665990-B | Chloride battery positive plate and preparation method thereof | 横店集团东磁股份有限公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-108276240-B | Method for synthesizing cyclohexane | 大连大学 | 2020-11-03 | — | — | CN | disclosed |
| CN-107785178-B | Chloride capacitor positive plate and preparation method thereof | 横店集团东磁股份有限公司 | 2020-09-29 | — | — | CN | disclosed |
| CN-107785176-B | Chloride capacitor positive electrode slurry and preparation method thereof | 横店集团东磁股份有限公司 | 2020-09-29 | — | — | CN | disclosed |
| CN-107785536-B | Chloride square battery and assembling method thereof | 横店集团东磁股份有限公司 | 2020-08-14 | — | — | CN | disclosed |
| EP-1537106-A1 | DIHYDROPYRAZOLOPYRIDINE COMPOUNDS | Mitsubishi Pharma Corporation (JP) | 2005-06-08 | — | — | EP | disclosed |
| CN-1517351-A | Copper-carbene complex and its application | ˹���ػ�ѧ��Ʒ�ɷ�����˾ | 2004-08-04 | — | — | CN | disclosed |
| WO-2004014910-A1 | DIHYDROPYRAZOLOPYRIDINE COMPOUNDS | MITSUBISHI PHARMA CORPORATION (JP) | 2004-02-19 | — | — | WO | disclosed |
| US-5859030-A | Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1999-01-12 | — | — | US | disclosed |
| EP-0835857-A1 | METHOD OF OBTAINING 1,2-DICHLOROETHANE | Caprolactam Joint-Stock Company (RU) | 1998-04-15 | — | — | EP | disclosed |
| US-4018782-A | 1-OXAPENICILLINS, ANTIBIOTICS | QUEEN'S UNIVERSITY (CA) | 1977-04-19 | — | — | US | disclosed |
| US-3985764-A | REACTING CHLORINATED ESTERS OF ANHYDROBENZYLPENICILLIN WITH ALUMINA OR SILICA GEL | QUEEN'S UNIVERSITY (CA) | 1976-10-12 | — | — | US | disclosed |
| US-3950352-A | ANTIBIOTICS, OXAPENICILLINS | QUEEN'S UNIVERSITY (CA) | 1976-04-13 | — | — | US | disclosed |
| US-3948927-A | ANTIBIOTIC INTERMEDIATE | QUEEN'S UNIVERSITY (CA) | 1976-04-06 | — | — | US | disclosed |